Wsw. Shalaby, DEVELOPMENT OF ORAL VACCINES TO STIMULATE MUCOSAL AND SYSTEMIC IMMUNITY - BARRIERS AND NOVEL STRATEGIES, Clinical immunology and immunopathology, 74(2), 1995, pp. 127-134
Many questions regarding the induction of mucosal and humoral immunity
through oral vaccination exist. Efficacy is dependent on the physicoc
hemical properties of the antigen, the gastrointestinal environment, t
he presence of adjuvants, and the mode of delivery. Understanding how
these factors interrelate will be critical to the development of new o
ral vaccines. A number of approaches are currently being studied to en
hance the immune response. These include chemical conjugation, immuniz
ation with recombinant bacteria and viruses, and mucosal adjuvants. Va
ccine delivery systems prepared from natural or synthetic polymers is
a particularly promising area because many of the current methods to i
nduce mucosal stimulation can be incorporated within these systems. Th
us, the polymeric delivery system functions as a platform to facilitat
e uptake by M-cells and prolong antigen presentation and stimulation o
f the Peyer's patches. This Review examines some of the physiological
and immunological barriers associated with oral vaccination and discus
ses novel strategies to overcome such barriers. (C) 1995 Academic Pres
s, Inc.